KROS
Keros Therapeutics Inc
11.60$
-0.9%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 101.1% | 173.5% | 24.2% | 4.5% | 8.1% | 539.7% | 34.6% | 0.6% | |
| -1.1% | -73.5% | -24.2% | 100.0% | -8.1% | 100.0% | 100.0% | 99.4% | |
| 101.1% | 173.8% | 1,354.4% | 274.3% | 436.3% | 89,574.8% | 4,891.0% | 53.1% | |
| 15.8% | 31.8% | 511.9% | 106.1% | 137.6% | 23,068.9% | 1,148.0% | 19.2% | |
| 113.2% | 200.1% | 1,842.1% | 380.5% | 573.9% | 112,643.7% | 6,039.0% | 70.4% | |
| -16.9% | -105.6% | -1,866.3% | -280.5% | -573.9% | -112,543.7% | -5,939.0% | 28.9% | |
| 0.1% | 0.1% | 0.2% | 0.0% | 0.0% | 0.0% | 0.0% | – | |
| -10.8% | -123.4% | -1,821.3% | -282.3% | -523.4% | -101,319.2% | -5,269.1% | 37.7% | |
| 2.6% | 0.1% | -6.9% | 10.0% | 0.0% | -136.4% | 8.5% | 2.0% | |
| -13.4% | -123.4% | -1,814.4% | -292.3% | -523.4% | -101,319.2% | -5,277.5% | 35.7% | |
| -7.7% | -118.9% | -1,796.9% | -280.4% | -520.0% | -100,779.5% | -5,234.5% | 38.3% |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.